Skip to main content

Metformin use and incidence cancer risk: evidence for a selective protective effect against liver cancer.


AUTHORS

Murff HJ , Roumie CL , Greevy RA , Hackstadt AJ , McGowan LED , Hung AM , Grijalva CG , Griffin MR , . Cancer causes & control : CCC. 2018 7 18; ().
  • NIHMSID: 9100846

ABSTRACT

Several observational studies suggest that metformin reduces incidence cancer risk; however, many of these studies suffer from time-related biases and several cancer outcomes have not been investigated due to small sample sizes.


Several observational studies suggest that metformin reduces incidence cancer risk; however, many of these studies suffer from time-related biases and several cancer outcomes have not been investigated due to small sample sizes.


Tags: